logo
Woman's work outfit sparks heated debate… so do YOU think the ensemble is appropriate?

Woman's work outfit sparks heated debate… so do YOU think the ensemble is appropriate?

Daily Mail​2 days ago

A woman's work outfit has sparked a heated debate about what's appropriate to wear to the office.
Alejandra Carreño, an employee at an affordable housing non-profit in California, recently revealed on TikTok that someone had 'complained' about her wearing 'short shorts' to work, and asked viewers if they thought the ensemble was OK for the workplace.
She wore a black long sleeve top, heeled sling-back shoes, and jean shorts that went about halfway down her thighs.
The non-profit employee wrote in a text overlay, 'Are my shorts inappropriate for work? Asking because someone complained about them,' as she showcased the 'fit to the camera.
'These were considered "short shorts,"' the caption read.
Alejandra told People that when she arrived at work, a few co-workers made comments about the outfit, but she didn't expect it to become a problem.
Later in the day, she stayed for a team meeting and her shorts became a topic of conversation.
'Oh, before I forget, I do have to tell you that someone mentioned a complaint about your shorts. Short shorts aren't allowed,' Alejandra recalled her manager saying.
Alejandra Carreño, an employee at an affordable housing non-profit in California, wore a black long sleeve top, heeled shoes, and jean shorts that went about halfway down her thighs
Her manager added, 'To me, they seemed fine. I didn't see anything wrong with them. I think you look nice.
'But unfortunately, I do need to let you know we can't wear short shorts or short skirts.'
Alejandra said she told her manager she wouldn't wear them again, but realized that her workplace's handbook says nothing about banning shorts at the office.
'Clothing should be clean, unstained, untorn, properly fitted, and free of inappropriate or suggestive content,' the policy reads, per Alejandra.
'Undergarments should not be visible, and overly tight or revealing clothes are not allowed.'
After hearing from her manager, she posted the now-viral video and it launched a massive argument in the comment section.
'Shorts should never be in an office,' one user wrote.
'If you had to ask then yes girl you knew,' another said.
'They're inappropriate as in they're not work attire. But they're not inappropriate in length,' someone else shared.
'That's not a work outfit at all. Sorry,' a fourth comment read, while a fifth said, 'Unless you work at a summer camp, girl.'
'If you have to ask if the 'fit is appropriate, it probably isn't,' someone else said.
A different person wrote: 'They're not short shorts, but they're not work-appropriate shorts either lol.'
'Young people really don't understand business casual lol,' another user admitted.
'If you work in an office, shorts are never appropriate,' another affirmed.
However, a few people were shocked that Alejandra's outfit was even questioned.
'These comments are crazy, how exactly do shorts prevent anyone from doing their job in an office?' someone wrote.
'I'm sorry, but am I the only one that thinks these are appropriate? Like guys, let's be real, we are in the year 2025 where shorts should not be an issue,' another said.
'I'm sorry y'all but I'm convinced corporate office culture is just a place where joy, whimsy, and personality go to die. Like…are we all really just gonna sit here and pretend shorts are ACTUALLY worth a complaint?' a user questioned.
Alejandra said this whole interaction has made her think deeply about dress codes.
'It's made me think more critically about how dress codes can be both necessary and limiting depending on how they're applied,' she told People.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Armie Hammer reunites with ex-wife and kids for milestone... after scary cannibalism scandal
Armie Hammer reunites with ex-wife and kids for milestone... after scary cannibalism scandal

Daily Mail​

time31 minutes ago

  • Daily Mail​

Armie Hammer reunites with ex-wife and kids for milestone... after scary cannibalism scandal

Armie Hammer had a rare reunion with his ex-wife Elizabeth Chambers to celebrate an important milestone with their eight-year-old son Ford. The 38-year-old actor and his 42-year-old ex Chambers share two children together, Ford and 10-year-old daughter Harper. The Social Network star and his entrepreneur/TV personality wife were married from 2010 until their split in 2020, with their divorce finalized in 2023, amid his cannibalism scandal. The exes have been co-parenting their children since the split, and they came together to celebrate Ford completing the second grade. Chambers shared a joyful snap of the exes and their kids, with Chambers sharing his second grade completion certificate. 'Happy 2nd Grade Step-Up Fordy Boy!' the doting mom said in the snap, with her son holding on to the family's dog. Armie was seen smiling in the snap with his arm around Harper, donning a black t-shirt, black pants and holding a black coat. Chambers donned a stylish black and white striped dress along with gold bracelets and gold earrings for the outing. Hammer shot to fame after playing the Winklevoss Twins in 2010's The Social Network, that was instrumental in launching his career. That rising career quickly came crashing down in 2021 when multiple accusations of sexual assault, rape and even cannibalism surfaced. While the LAPD launched an investigation, no charges were filed against the actor, who has admitted to consensual BDSM and emotional abuse, but denies all sexual assault and cannibalism charges, which stemmed from a woman named Courtney Vucekovich who alleged he said he wanted to cook and eat one of her ribs. Chambers recently promoted her upcoming show Toxic on The Today Show, where she admitted that things were great with her ex and children. 'They're amazing. We're amazing. I think we've never been stronger as a family,' Chambers said. 'This show touches on domestic violence, it touches on really unhealthy patterns. For me, I just experienced betrayal,' she said of her relationship with Hammer. 'But in that process, I really learned so much about patterns and how parenting, really it comes down to parenting,' Chambers added. 'It comes down to humanity and psychology and all of those interesting things,' she said, while admitting she's not a fan of the term 'co-parenting.' 'I don't love that word co-parenting, right? I think we're just parents and everyone is just parenting as well as they can with what they have,' Chambers said. 'Our family is, again, so strong and better than ever. But for me, divorce in itself is just trauma, Chambers admitted.

Millions of doses of ‘pandemic-ending' HIV jab at risk over Trump's aid cuts
Millions of doses of ‘pandemic-ending' HIV jab at risk over Trump's aid cuts

The Independent

time31 minutes ago

  • The Independent

Millions of doses of ‘pandemic-ending' HIV jab at risk over Trump's aid cuts

Professor Linda-Gail Bekker recalls having 'shivers' when she found out that not one single woman given a revolutionary new jab in her medical trial had caught HIV. She told a global Aids summit last year that she 'literally burst into tears.' Now, she tells The Independent, that emotion has turned into an 'acute sense of despair '. The funding to get lenacapavir – a twice-yearly preventative jab that has been described as the nearest thing we have to an HIV vaccine – out to at least two million people around the globe is in question amid the turmoil accompanying Donald Trump decision to slash US aid spending. Lenacapavir stops HIV from replicating meaning that, as long as someone is on the drug, they are almost totally protected from developing the virus if they are exposed to it. Prof Bekker's study found a 96 per cent reduction in HIV overall - but in the arm of the trial looking at women and adolescent girls, there were no infections at all. Global funders, led by Pepfar and the Global Fund, in December promised to secure enough doses of the jab to protect at least two million people over three years. Its manufacturer Gilead says it will sell these at no profit, though it has not made the cost of a dose public. Gilead has also signed agreements with six pharmaceutical companies in India, Pakistan, Egypt, and the US to allow them to make generic versions of the drug in order to increase supply and drive down the cost of the jab. A significant chunk of the money to fund the doses of lenacapavir was set to come from the US-led global Aids response programme, the US President's Emergency Plan for Aids Relief (Pepfar). But this funding, and the future of Pepfar itself, is now uncertain. 'In all of the excitement [of the trial results] we were thinking, well, what do you do with [the] doses? What's the best way to use it?' Prof Bekker says. 'Suddenly, that is very much up in the air'. The other main funding source, the Global Fund to Fight AIDS, Tuberculosis and Malaria has said that it still aims to fund the doses of lenacapavir. Speaking to The Independent, however, Global Fund executive director Peter Sands tempers this by saying the success of his organisation's funding round coming up later this year would, 'determine how much scope we have for this'. The US was the Global Fund's biggest donor. Sands says that while he would 'love to say' the Global Fund could fill the gap, this would be contingent on how much money is raised from governments and private donors. "Despite all the uncertainties both around Pepfar and our own future funding, we are still very keen to deliver on the ambition,' Sands says. But, more funding than they have currently been pledged will be needed to, 'realise the full potential of lenacapavir'. At the World Health Organisation (WHO)'s annual decision-making meeting which concluded late last month, the United Nations' Aids agency (UNAIDS) called for 'urgent action to avoid millions of avoidable HIV infections and Aids-related deaths,' saying this included, 'access to long-acting injectables for HIV prevention which are almost 100 per cent effective at preventing infections' – a nod to lenacapavir. 'A missed opportunity' Prof Bekker played a crucial role in trialling the jab in eight countries including her home country of South Africa, and she was on the brink of seeing that breakthrough rolled out – it could have been in people's arms by the end of this year. Long-acting jabs like lenacapavir are not only about protecting individuals, they are a crucial part of ending the Aids pandemic, Prof Bekker explains. 'A six-monthly injectable is as close as we can get at this moment to a vaccine,' Prof Bekker says. Just like with a vaccine, it can help keep whole populations safe by stopping vulnerable people from catching the virus and then potentially spreading the virus to more people. 'You finally have something that could actually bring us to a conclusion [of the Aids crisis]. 'It just feels like such a calamitous missed opportunity,' she says. Overcoming stigma A daily preventative medicine – a combination of two drugs known collectively as pre-exposure prophylaxis (PrEP) – is already available and is very effective. But people without reliable access to healthcare find it harder to maintain a regime that involves regular pills. Girls, young women and LGBT+ people in Southern Africa can also face questioning from family members if they have packets of daily pills in their homes which indicate they are sexually active, and it can put women in relationships at higher risk of domestic violence. A six-monthly jab on the other hand can be maintained more discreetly and with less user error. Offering lenacapavir to young women – among the hardest to reach with HIV prevention - when they book into prenatal care can also prevent them from passing the virus onto their children. 'That is a good use of money, right?' Prof Bekker says. 'You're saving two infections; one of them a lifelong infection in a child that will need antivirals for the next 70 to 75 years'. 'They are young people in front of us. We can introduce them to Republican Congressmen if needed'. A State Department spokesperson said: 'Pepfar continues to support lifesaving HIV testing, care and treatment, and prevention of mother to child transmission services approved by the Secretary of State. 'As directed by the Secretary of State all other Pepfar-funded services are being reviewed for assessment of programmatic efficiencies and consistency with United States foreign policy. Pepfar, like all assistance programmes, should be reduced over time as it achieves its mission.' Ending Aids Figures previously reported by The Independent suggest Trump's slashing of foreign aid has derailed the projected end of the Aids pandemic and could lead to four million extra deaths by 2030. The latest global figures show there were 1.3 million new HIV infections and roughly 630,00 people dying from Aids around the world in 2023. Regardless of the cuts, before any doses can be made available, the drug has to be approved by regulators. The US Food and Drug Administration (FDA)'s decision is understood to be on track to approve the preventative jab on 19 June, followed by other national medicines regulators and the WHO. Before the cuts, an FDA approval would have marked the moment it would be full steam ahead to roll lenacapavir out to the people who need it most. But those approvals won't count for much if the money to pay for the drug and get it out to the people who need it doesn't materialise, as Prof Bekker fears. 'It does feel like this thing that could help us end the epidemic sooner is suddenly receding in the chaos'.

Friends actor warns Jewish people ‘the cavalry aint coming' after Colorado flamethrower attack
Friends actor warns Jewish people ‘the cavalry aint coming' after Colorado flamethrower attack

The Independent

time31 minutes ago

  • The Independent

Friends actor warns Jewish people ‘the cavalry aint coming' after Colorado flamethrower attack

Friends actor Michael Rapaport has warned Jewish people that 'the cavalry ain't coming' after a horrific flamethrower attack at a pro-Israel march in Boulder, Colorado. On an episode of his podcast 'I Am Rapaport' that was released Tuesday, Rapaport, who played Phoebe Buffay's boyfriend Gary on the hit TV show Friends, spoke out about the terror attack last Sunday that left 12 demonstrators injured. 'What's going on in the world for Jewish people, what's going on in the world for people that support and believe in the right of the existence of Israel, a.k.a. Zionists, is frightening,' Rapaport said. Rapaport, who is Jewish, said, 'I don't think I have felt scared since October 7,' referring to Hamas' deadly attack on Israel in 2023. The actor said that he has spoken out for other groups in their time of need, but now no one is supporting him and his fellow Jewish and Zionist people. 'I put a f***ing black square [on social media] like a f***ing a****** during Black Lives Matter. Don't you feel like an a****** now? For putting up a black square during Black Lives Matter when nobody is coming and saying anything on our behalf.' Rapaport said that he's been traveling all over the U.S. and in Israel as an outspoken supporter of Israel for the last '500 days.' 'All the time people go, 'Why isn't anyone saying anything … Do you feel ignored, do you feel alienated?' Yes, yes, yes,' he said. The actor continued: 'I'm telling you something, Jewish people, the cavalry ain't coming. The cavalry is not coming for us. They don't give a f***.' 'It's sad, it's frustrating. You feel used. You feel manipulated. You feel like a sucker. I feel like it, too!' he added. Mohamed Sabry Soliman, a 45-year-old Egyptian national, was arrested and charged with a federal hate crime and 16 counts of attempted murder in connection with the attack. He had entered the US on a visa that expired two years ago and was subsequently granted work authorization, which expired last March. The suspect told authorities he spent a year planning the attack and specifically targeted a 'Zionist group.' Witnesses reported Soliman shouting 'Free Palestine!' before firing a 'makeshift flamethrower' and Molotov cocktails, per the FBI. The victims were participating in a 'Run For Their Lives' event in support of the release of the remaining hostages held in Gaza.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store